immune checkpoint inhibitors in squamous non-small cell lung cancer
Published 8 years ago • 162 plays • Length 7:42Download video MP4
Download video MP3
Similar videos
-
8:16
immune checkpoint inhibitor combinations in non-small cell lung cancer
-
4:47
immune checkpoint inhibitors in small-cell lung cancer
-
7:54
immune checkpoint inhibitors in nsclc
-
8:00
immunotherapy for squamous non-small cell lung cancer
-
8:21
safety of pd-1 inhibitors in squamous non-small cell lung cancer
-
5:24
checkpoint inhibition squamous cell and nonsquamous cell nsclc
-
6:42
pseudoprogression with checkpoint inhibitors in non-small cell lung cancer
-
12:33
introduction: checkpoint inhibition in non-small cell lung cancer
-
4:52
targeting the immune system in non-small cell lung cancer
-
1:19
immune checkpoint inhibitors, durvalumab plus tremelimumab, for non-small cell lung cancer
-
40:21
extending horizons with immune checkpoint inhibitors in small cell lung cancer: 2022 perspectives
-
7:34
pd-l1 as a biomarker in squamous non-small cell lung cancer
-
1:06
checkpoint inhibitors advance standard of care for non-small cell lung cancers
-
7:22
pd-1 inhibition in lung cancer
-
7:55
emerging checkpoint inhibitors for lung cancer
-
3:46
understanding immunotherapy for lung cancer
-
5:23
checkpoint inhibitors in nsclc
-
5:32
ipilimumab in squamous non-small cell lung cancer
-
1:20
resistance to immune checkpoint blockade in patients with cscc